Athenex Inc ATNX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:46 PM EDT
3.18quote price arrow up+0.03 (+0.95%)
Volume
9,605
Close
3.15quote price arrow down-0.13 (-3.96%)
Volume
675,528
52 week range
3.12 - 15.00
Loading...
  • Open3.24
  • Day High3.28
  • Day Low3.14
  • Prev Close3.28
  • 52 Week High15.00
  • 52 Week High Date02/10/21
  • 52 Week Low3.12
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap344.33M
  • Shares Out109.31M
  • 10 Day Average Volume2.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-71.52

KEY STATS

  • Open3.24
  • Day High3.28
  • Day Low3.14
  • Prev Close3.28
  • 52 Week High15.00
  • 52 Week High Date02/10/21
  • 52 Week Low3.12
  • 52 Week Low Date08/20/21
  • Market Cap344.33M
  • Shares Out109.31M
  • 10 Day Average Volume2.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-71.52

RATIOS/PROFITABILITY

  • EPS (TTM)-1.57
  • P/E (TTM)-2.01
  • Fwd P/E (NTM)-2.37
  • EBITDA (MRQ)-131.641M
  • ROE (MRQ)-89.75%
  • Revenue (MRQ)120.23M
  • Gross Margin (MRQ)34.42%
  • Net Margin (MRQ)-123.00%
  • Debt To Equity (MRQ)80.99%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Athenex Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel, and an oral...
Johnson Lau M.D.
Chairman
Jeffrey Yordon
Chief Operating Officer
Steven Adams
Chief Financial Officer
Address
1001 Main St Ste 600
Buffalo, NY
14203-1009
United States

Top Peers

SYMBOLLASTCHG%CHG
HBIO
Harvard Bioscience Inc
7.41-0.40-5.12%
CPRX
Catalyst Pharmaceuticals Inc
5.05-0.14-2.70%
KPTI
Karyopharm Therapeutics Inc
6.09-0.43-6.60%
SURF
Surface Oncology Inc
7.23-0.32-4.24%
JNCE
Jounce Therapeutics Inc
7.90-0.15-1.86%